
Eliprodil
CAS No. 119431-25-3
Eliprodil ( SL-820715 )
产品货号. M10679 CAS No. 119431-25-3
Eliprodil (SL-820715) 是一种非竞争性 NR2B-NMDA 受体拮抗剂,对包含 NR2A 和 NR2C 的受体作用较弱 (IC50>100 uM)。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥413 | 有现货 |
![]() ![]() |
10MG | ¥745 | 有现货 |
![]() ![]() |
25MG | ¥1434 | 有现货 |
![]() ![]() |
50MG | ¥2738 | 有现货 |
![]() ![]() |
100MG | ¥4155 | 有现货 |
![]() ![]() |
500MG | ¥8748 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Eliprodil
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Eliprodil (SL-820715) 是一种非竞争性 NR2B-NMDA 受体拮抗剂,对包含 NR2A 和 NR2C 的受体作用较弱 (IC50>100 uM)。
-
产品描述Eliprodil (SL-820715) is a non-competitive NR2B-NMDA receptor antagonist, less potent for NR2A- and NR2C-containing receptors (IC50>100 uM); inhibits [3H]norepinephrine release from cortical and hippocampal slices but enhances the basal efflux of endogenous and tritiated dopamine from striatal slices, also blocks the uptake of [3H]dopamine into striatal synaptosomes with IC50 of 1.5 uM; reduces the volume of infarction in models of focal cerebral ischemia.Stroke Phase 3 Discontinued.
-
体外实验——
-
体内实验——
-
同义词SL-820715
-
通路Membrane Transporter/Ion Channel
-
靶点iGluR
-
受体NR2B-NMDA
-
研究领域Neurological Disease
-
适应症Stroke
化学信息
-
CAS Number119431-25-3
-
分子量347.8541
-
分子式C20H23ClFNO
-
纯度>98% (HPLC)
-
溶解度10 mM in DMSO
-
SMILESOC(C1=CC=C(Cl)C=C1)CN2CCC(CC3=CC=C(F)C=C3)CC2
-
化学全称1-Piperidineethanol, α-(4-chlorophenyl)-4-[(4-fluorophenyl)methyl]-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Woodward JJ, et al. Eur J Pharmacol. 1992 Jan 21;210(3):265-70.
2. Carter CJ, et al. J Pharmacol Exp Ther. 1990 May;253(2):475-82.
3. Carter C, et al. Eur J Pharmacol. 1989 May 30;164(3):611-2.
4. Bath CP, et al. Eur J Pharmacol. 1996 Mar 28;299(1-3):103-12.